Education
About Us
Working with TipRanks
Follow Us
IN8bio (INAB)
NASDAQ:INAB
Total Valuation
IN8bio has a market cap or net worth of $17.38M. The enterprise value is $518.83K.
Market Cap$17.38M
Enterprise Value$518.83K
Share Statistics
IN8bio has 9,766,132 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,766,132
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
IN8bio’s return on equity (ROE) is -2.10 and return on invested capital (ROIC) is -156.02%.
Return on Equity (ROE)-2.10
Return on Assets (ROA)-1.45
Return on Invested Capital (ROIC)-156.02%
Return on Capital Employed (ROCE)-1.70
Revenue Per Employee0.00
Profits Per Employee-1.69M
Employee Count18
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of IN8bio is ―. IN8bio’s PEG ratio is 0.32.
PE Ratio―
PS Ratio0.00
PB Ratio28.55
Price to Fair Value28.55
Price to FCF-17.04
Price to Operating Cash Flow-0.55
PEG Ratio0.32
Income Statement
In the last 12 months, IN8bio had revenue of 0.00 and earned -30.44M in profits. Earnings per share was -0.57.
Revenue0.00
Gross Profit0.00
Operating Income-30.44M
Pretax Income-30.44M
Net Income-30.44M
EBITDA-26.94M
Earnings Per Share (EPS)-0.57
Cash Flow
In the last 12 months, operating cash flow was -14.60M and capital expenditures -33.00K, giving a free cash flow of -14.63M billion.
Operating Cash Flow-14.60M
Free Cash Flow-14.63M
Free Cash Flow per Share-1.50
Dividends & Yields
IN8bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.85
52-Week Price Change-77.78%
50-Day Moving Average2.01
200-Day Moving Average2.40
Relative Strength Index (RSI)38.79
Average Volume (3m)74.58K
Important Dates
IN8bio upcoming earnings date is Mar 12, 2026, After Close (Confirmed).
Last Earnings DateNov 6, 2025
Next Earnings DateMar 12, 2026
Ex-Dividend Date―
Financial Position
IN8bio as a current ratio of 4.08, with Debt / Equity ratio of 22.42%
Current Ratio4.08
Quick Ratio4.08
Debt to Market Cap<0.01
Net Debt to EBITDA0.23
Interest Coverage Ratio0.00
Taxes
In the past 12 months, IN8bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
IN8bio EV to EBITDA ratio is -15.12, with an EV/FCF ratio of -16.79.
EV to Sales0.00
EV to EBITDA-15.12
EV to Free Cash Flow-16.79
EV to Operating Cash Flow-16.87
Balance Sheet
IN8bio has $10.69M in cash and marketable securities with $2.96M in debt, giving a net cash position of $7.73M billion.
Cash & Marketable Securities$10.69M
Total Debt$2.96M
Net Cash$7.73M
Net Cash Per Share$0.79
Tangible Book Value Per Share$0.27
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for IN8bio is $5.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$5.50
Price Target Upside208.99% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast70.57%